Cargando…

Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies

BACKGROUND: Papillary and follicular thyroid carcinomas can be treated surgically and with radioiodine therapy, whereas therapeutic options for advanced stage IV medullary and for anaplastic tumours are limited. Recently, somatostatin receptors (SSTs) and the chemokine receptor CXCR4 have been evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czajkowski, Max, Kaemmerer, Daniel, Sänger, Jörg, Sauter, Guido, Wirtz, Ralph M., Schulz, Stefan, Lupp, Amelie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261050/ https://www.ncbi.nlm.nih.gov/pubmed/35799158 http://dx.doi.org/10.1186/s12885-022-09839-z

Ejemplares similares

Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
por: Kaemmerer, Daniel, et al.
Publicado: (2017)

Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61
por: Ehms, Blanca, et al.
Publicado: (2022)

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
por: Mai, Rebekka, et al.
Publicado: (2019)

Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
por: Kaemmerer, Daniel, et al.
Publicado: (2015)

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
por: Kaemmerer, Daniel, et al.
Publicado: (2017)

Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies
por: Werner, Christoph, et al.
Publicado: (2020)

Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody
por: Bubb, Maria, et al.
Publicado: (2022)

Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody
por: Herzig, Markus, et al.
Publicado: (2019)

Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
por: Kaemmerer, Daniel, et al.
Publicado: (2014)

Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
por: Neubauer, Elisa, et al.
Publicado: (2016)

Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data
por: Rösner, Erik, et al.
Publicado: (2022)

Prognostic value of PD-L1 expression in bronchopulmonary neuroendocrine tumours
por: Rösner, Erik, et al.
Publicado: (2021)

Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study
por: Beyer, Anna-Sophia Liselott, et al.
Publicado: (2022)

Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues
por: Nürge, Benjamin, et al.
Publicado: (2021)

Immunohistochemical Evaluation of Adaptor Protein FAM159B Expression in Normal and Neoplastic Human Tissues
por: Beyer, Anna-Sophia Lieselott, et al.
Publicado: (2021)

Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues
por: Wende, Benjamin, et al.
Publicado: (2023)

Expression of G protein-coupled receptor GPR19 in normal and neoplastic human tissues
por: Gerlach, Lorena, et al.
Publicado: (2023)

Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61
por: Lupp, Amelie, et al.
Publicado: (2021)

Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
por: Oron-Herman, Mor, et al.
Publicado: (2023)

CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney
por: Haege, Sammy, et al.
Publicado: (2012)

International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
por: Günther, Thomas, et al.
Publicado: (2018)

Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer?
por: Ingold, Barbara, et al.
Publicado: (2010)

The relevance of somatostatin receptors in thyroid neoplasia.
por: Ahlman, H., et al.
Publicado: (1997)

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy
por: Hudson, R, et al.
Publicado: (2005)

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
por: Bruynck, A., et al.
Publicado: (1993)

Characterisation of a novel A1-specific monoclonal antibody
por: Lang, M J, et al.
Publicado: (2014)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
por: Rees, Jennifer, et al.
Publicado: (2017)

Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes
por: Juntikka, Tiina, et al.
Publicado: (2021)

Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2
por: Fischer, Thomas, et al.
Publicado: (2008)

Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies
por: Carillo, Sara, et al.
Publicado: (2020)

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid
por: Tisell, L E, et al.
Publicado: (1999)

Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
por: ZHU, XIAOLI, et al.
Publicado: (2016)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer
por: Taromi, Sanaz, et al.
Publicado: (2017)

Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
por: Rowe, D. J., et al.
Publicado: (1984)

Production and characterisation of a monoclonal antibody (Cx-99) against cervical carcinoma.
por: Yuan, C. C., et al.
Publicado: (1992)

Development of an anti-ferret CD4 monoclonal antibody for the characterisation of ferret T lymphocytes
por: Layton, Daniel S., et al.
Publicado: (2017)

Generation and Characterisation of Monoclonal Antibodies against Nairobi Sheep Disease Virus Nucleoprotein
por: Maze, Emmanuel A., et al.
Publicado: (2023)

The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease
por: Krassas, Gerasimos E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bmpu17n0d4v2g2ps9pg0dtt7jd